{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:17:08Z","timestamp":1791087428804,"version":"4.1.0"},"reference-count":153,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/shk.0b013e3181598bad","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T11:47:58Z","timestamp":1236253678000},"page":"431-440","source":"Crossref","is-referenced-by-count":94,"title":["HEXOSAMINE BIOSYNTHESIS AND PROTEIN O-GLYCOSYLATION"],"prefix":"10.1097","volume":"29","author":[{"given":"John C.","family":"Chatham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo G.","family":"N\u00f6t","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"F\u00fcl\u00f6p","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard B.","family":"Marchase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-2-20210213","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1146\/annurev.physiol.67.040403.103635","article-title":"Molecular and evolutionary basis of the cellular stress response.","volume":"67","author":"Kultz","year":"2005","journal-title":"Annu Rev Physiol"},{"key":"R2-2-20210213","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1053\/beem.2001.0168","article-title":"Alterations in fuel metabolism in critical illness: hyperglycaemia.","volume":"15","author":"Mizock","year":"2001","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"R3-2-20210213","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1177\/0148607106030002157","article-title":"Metabolic mechanisms of stress hyperglycemia.","volume":"30","author":"Mechanick","year":"2006","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"R4-2-20210213","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients.","volume":"345","author":"van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"R5-2-20210213","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.2337\/diabetes.55.04.06.db05-1434","article-title":"Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin.","volume":"55","author":"Ellger","year":"2006","journal-title":"Diabetes"},{"key":"R6-2-20210213","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/archinte.164.18.2005","article-title":"Insulin therapy for critically ill hospitalized patients: a meta-analysis of randomized controlled trials.","volume":"164","author":"Pittas","year":"2004","journal-title":"Arch Intern Med"},{"key":"R7-2-20210213","first-page":"433","article-title":"The effect of hyperosmolar infusions on survival after hemorrhage.","volume":"155","author":"Ljungqvist","year":"1989","journal-title":"Acta Chir Scand"},{"key":"R8-2-20210213","first-page":"1","article-title":"Pretreatment with glucose infusion prevents fatal outcome after hemorrhage in food deprived rats.","volume":"39","author":"Alibegovic","year":"1993","journal-title":"Circ Shock"},{"key":"R9-2-20210213","first-page":"465","article-title":"Hyperglycaemia and survival after haemorrhage.","volume":"160","author":"Ljungqvist","year":"1994","journal-title":"Eur J Surg"},{"key":"R10-2-20210213","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/S0899-9007(96)00165-7","article-title":"Pre-stress carbohydrate solution prevents fatal outcome after hemorrhage in 24-hour food-deprived rats.","volume":"12","author":"Nettelbladt","year":"1996","journal-title":"Nutrition"},{"key":"R11-2-20210213","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1748-1716.1973.tb05514.x","article-title":"Osmotic fluid transfer from tissue to blood during hemorrhagic hypotension.","volume":"89","author":"Jarhult","year":"1973","journal-title":"Acta Physiol Scand"},{"key":"R12-2-20210213","first-page":"1","article-title":"Contribution of glucose to the hyperosmolality of prolonged hypovolemia.","volume":"43","author":"Stone","year":"1977","journal-title":"Am Surg"},{"key":"R13-2-20210213","first-page":"43","article-title":"Influence of hyperglycemia on survival after hemorrhagic shock.","volume":"1","author":"Menguy","year":"1978","journal-title":"Adv Shock Res"},{"key":"R14-2-20210213","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/00005373-198202000-00002","article-title":"The role of blood glucose in defense of plasma volume during hemorrhage.","volume":"22","author":"Friedman","year":"1982","journal-title":"J Trauma"},{"key":"R15-2-20210213","first-page":"641","article-title":"Osmolar changes in haemorrhage: the effects of an altered nutritional status.","volume":"148","author":"Ware","year":"1982","journal-title":"Acta Chir Scand"},{"key":"R16-2-20210213","doi-asserted-by":"crossref","first-page":"C178","DOI":"10.1152\/ajpcell.00162.2006","article-title":"Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury via increased protein-associated O-GlcNAc.","volume":"292","author":"Champattanachai","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"R17-2-20210213","doi-asserted-by":"crossref","first-page":"30133","DOI":"10.1074\/jbc.M403773200","article-title":"Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells.","volume":"279","author":"Zachara","year":"2004","journal-title":"J Biol Chem"},{"key":"R18-2-20210213","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1161\/01.RES.0000103190.20260.37","article-title":"Proteomic approaches to analyze the dynamic relationships between nucleocytoplasmic protein glycosylation and phosphorylation.","volume":"93","author":"Whelan","year":"2003","journal-title":"Circ Res"},{"issue":"312","key":"R19-2-20210213","first-page":"re13","article-title":"The hexosamine signaling pathway: deciphering the \"O-GlcNAc code\".","author":"Love","year":"2005","journal-title":"Sci STKE"},{"key":"R20-2-20210213","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.bbalip.2006.04.007","article-title":"Cell signaling, the essential role of O-GlcNAc!","volume":"1761","author":"Zachara","year":"2006","journal-title":"Biochim Biophys Acta"},{"key":"R21-2-20210213","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1074\/mcp.M600453-MCP200","article-title":"Dynamic interplay between O-GlcNAcylation and GSK-3-dependent phosphorylation.","volume":"6","author":"Wang","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"R22-2-20210213","doi-asserted-by":"crossref","first-page":"13132","DOI":"10.1073\/pnas.0403471101","article-title":"Exploring the O-GlcNAc proteome: direct identification of O-GlcNAc-modified proteins from the brain.","volume":"101","author":"Khidekel","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-2-20210213","doi-asserted-by":"crossref","first-page":"44230","DOI":"10.1074\/jbc.M303810200","article-title":"Diabetes and the accompanying hyperglycemia impairs cardiomyocyte cycling through increased nuclear O-GlcNAcylation.","volume":"278","author":"Clark","year":"2003","journal-title":"J Biol Chem"},{"key":"R24-2-20210213","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/en.2005-0523","article-title":"Posttranslational, reversible O-glycosylation is stimulated by high glucose and mediates plasminogen activator inhibitor-1 gene expression and Sp1 transcriptional activity in glomerular mesangial cells.","volume":"147","author":"Goldberg","year":"2006","journal-title":"Endocrinology"},{"key":"R25-2-20210213","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.2337\/diabetes.50.10.2363","article-title":"Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death.","volume":"50","author":"Fiordaliso","year":"2001","journal-title":"Diabetes"},{"key":"R26-2-20210213","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0003-9861(03)00234-0","article-title":"The transcription factor PDX-1 is post-translationally modified by O-linked N-acetylglucosamine and this modification is correlated with its DNA binding activity and insulin secretion in min6 beta-cells.","volume":"415","author":"Gao","year":"2003","journal-title":"Arch Biochem Biophys"},{"key":"R27-2-20210213","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/glycob\/cwl067","article-title":": Elevation of the post-translational modification of proteins by O-linked N-acetylglucosamine leads to deterioration of the glucose-stimulated insulin secretion in the pancreas of diabetic Goto-Kakizaki rats.","volume":"17","author":"Akimoto","year":"2007","journal-title":"Glycobiology"},{"key":"R28-2-20210213","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/diabetes.51.4.1146","article-title":"Flux through the hexosamine pathway is a determinant of nuclear factor kappaB-dependent promoter activation.","volume":"51","author":"James","year":"2002","journal-title":"Diabetes"},{"key":"R29-2-20210213","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1096\/fasebj.21.6.A1278-d","article-title":"The protective effect of glucosamine on cardiac function following trauma hemorrhage: downregulation of cardiac NF-B signaling.","volume":"21","author":"Zou","year":"2007","journal-title":"FASEB J"},{"key":"R30-2-20210213","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1167\/iovs.05-1008","article-title":"Glucosamine sulfate inhibits TNF-alpha and IFN-gamma-induced production of ICAM-1 in human retinal pigment epithelial cells in vitro.","volume":"47","author":"Chen","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R31-2-20210213","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.2337\/diabetes.48.8.1562","article-title":"Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance of early postreceptor insulin signaling events in skeletal muscle.","volume":"48","author":"Patti","year":"1999","journal-title":"Diabetes"},{"key":"R32-2-20210213","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/01.CIR.0000023043.02648.51","article-title":"Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells.","volume":"106","author":"Federici","year":"2002","journal-title":"Circulation"},{"key":"R33-2-20210213","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1096\/fj.03-0725fje","article-title":": Increased O-glycosylation of insulin signaling proteins results in their impaired activation and enhanced susceptibility to apoptosis in pancreatic beta-cells.","volume":"18","author":"D'Alessandris","year":"2004","journal-title":"FASEB J"},{"key":"R34-2-20210213","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/emm.2005.30","article-title":"O-GlcNAc modification on IRS-1 and Akt2 by PUGNAc inhibits their phosphorylation and induces insulin resistance in rat primary adipocytes.","volume":"37","author":"Park","year":"2005","journal-title":"Exp Mol Med"},{"key":"R35-2-20210213","doi-asserted-by":"crossref","first-page":"E241","DOI":"10.1152\/ajpendo.00060.2002","article-title":"Enhanced O-GlcNAc protein modification is associated with insulin resistance in GLUT1-overexpressing muscles.","volume":"283","author":"Buse","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R36-2-20210213","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1016\/j.febslet.2006.04.051","article-title":"Akt1 is dynamically modified with O-GlcNAc following treatments with PUGNAc and insulin-like growth factor-1.","volume":"580","author":"Gandy","year":"2006","journal-title":"FEBS Lett"},{"key":"R37-2-20210213","doi-asserted-by":"crossref","first-page":"5313","DOI":"10.1073\/pnas.072072399","article-title":"Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3T3-L1 adipocytes.","volume":"99","author":"Vosseller","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R38-2-20210213","doi-asserted-by":"crossref","first-page":"10983","DOI":"10.1074\/jbc.275.15.10983","article-title":"Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity.","volume":"275","author":"Lubas","year":"2000","journal-title":"J Biol Chem"},{"key":"R39-2-20210213","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1074\/mcp.M200048-MCP200","article-title":"Mapping sites of O-GlcNAc modification using affinity tags for serine and threonine post-translational modifications.","volume":"1","author":"Wells","year":"2002","journal-title":"Mol Cell Proteomics"},{"key":"R40-2-20210213","doi-asserted-by":"crossref","first-page":"20636","DOI":"10.1074\/jbc.M312139200","article-title":"Hyperglycemia and inhibition of glycogen synthase in streptozotocin-treated mice: role of O-linked N-acetylglucosamine.","volume":"279","author":"Parker","year":"2004","journal-title":"J Biol Chem"},{"key":"R41-2-20210213","doi-asserted-by":"crossref","first-page":"10022","DOI":"10.1074\/jbc.M207787200","article-title":"Insulin resistance of glycogen synthase mediated by O-linked N-acetylglucosamine.","volume":"278","author":"Parker","year":"2003","journal-title":"J Biol Chem"},{"key":"R42-2-20210213","doi-asserted-by":"crossref","first-page":"12222","DOI":"10.1073\/pnas.97.22.12222","article-title":"Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation.","volume":"97","author":"Du","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R43-2-20210213","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.1074\/jbc.M414066200","article-title":"Protein O-GlcNAc modulates motility-associated signaling intermediates in neutrophils.","volume":"280","author":"Kneass","year":"2005","journal-title":"J Biol Chem"},{"key":"R44-2-20210213","doi-asserted-by":"crossref","first-page":"H2227","DOI":"10.1152\/ajpheart.01091.2006","article-title":"Glucosamine cardioprotection in perfused rat heart associated with increased O-linked N-acetylglucosamine protein modification and altered p38 activation.","volume":"292","author":"Fulop","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R45-2-20210213","doi-asserted-by":"crossref","first-page":"3578","DOI":"10.1021\/bi951918j","article-title":"Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin.","volume":"35","author":"Roquemore","year":"1996","journal-title":"Biochemistry"},{"key":"R46-2-20210213","first-page":"A1113","article-title":"O-Glycosylation of Thr-170 triggers the translocation of alpha B-crystallin in neonatal rat ventricular myocytes (NRVM) in response to stress.","volume":"19","author":"Krishnamoorthy","year":"2005","journal-title":"FASEB J"},{"key":"R47-2-20210213","doi-asserted-by":"crossref","first-page":"E424","DOI":"10.1152\/ajpendo.00382.2002","article-title":"High glucose and insulin promote O-GlcNAc modification of proteins, including alpha-tubulin.","volume":"284","author":"Walgren","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R48-2-20210213","doi-asserted-by":"crossref","first-page":"10570","DOI":"10.1074\/jbc.M010411200","article-title":"Alternative O-glycosylation\/O-phosphorylation of serine-16 in murine estrogen receptor beta: post-translational regulation of turnover and transactivation activity.","volume":"276","author":"Cheng","year":"2001","journal-title":"J Biol Chem"},{"key":"R49-2-20210213","doi-asserted-by":"crossref","first-page":"7172","DOI":"10.1074\/jbc.M607362200","article-title":"Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes.","volume":"282","author":"Luo","year":"2007","journal-title":"J Biol Chem"},{"key":"R50-2-20210213","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1096\/fasebj.21.6.A866","article-title":"Glucosamine protects neonatal cardiomyocytes from ischemia-reperfusion injury through translocation of Bcl2 family proteins.","volume":"21","author":"Champattanachai","year":"2007","journal-title":"FASEB J"},{"key":"R51-2-20210213","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/jcp.20609","article-title":": Inhibition of phospholipase C-beta1-mediated signaling by O-GlcNAc modification.","volume":"207","author":"Kim","year":"2006","journal-title":"J Cell Physiol"},{"key":"R52-2-20210213","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1055\/s-0029-1212002","article-title":"Glucosamine induces translocation of protein kinase C isoenzymes in mesangial cells.","volume":"106","author":"Kolm-Litty","year":"1998","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"R53-2-20210213","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.bbamcr.2004.11.001","article-title":"Selective decrease of membrane-associated PKC-alpha and PKC-epsilon in response to elevated intracellular O-GlcNAc levels in transformed human glial cells.","volume":"1743","author":"Matthews","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"R54-2-20210213","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI11235","article-title":"Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.","volume":"108","author":"Du","year":"2001","journal-title":"J Clin Invest"},{"key":"R55-2-20210213","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S0092-8674(03)00974-7","article-title":"O-GlcNAc modification is an endogenous inhibitor of the proteasome.","volume":"115","author":"Zhang","year":"2003","journal-title":"Cell"},{"key":"R56-2-20210213","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/01.ATV.0000112012.33770.2a","article-title":"High glucose-induced upregulation of osteopontin is mediated via Rho\/Rho kinase pathway in cultured rat aortic smooth muscle cells.","volume":"24","author":"Kawamura","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R57-2-20210213","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/01.shk.0000209563.07693.db","article-title":"Glucosamine administration during resuscitation improves organ function after trauma hemorrhage.","volume":"25","author":"Yang","year":"2006","journal-title":"Shock"},{"key":"R58-2-20210213","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/01.shk.0000245031.31859.29","article-title":"PUGNAc administration during resuscitation improves organ function following trauma-hemorrhage.","volume":"27","author":"Zou","year":"2007","journal-title":"Shock"},{"key":"R59-2-20210213","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yjmcc.2006.09.015","article-title":"Glutamine-induced protection of isolated rat heart from ischemia\/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.","volume":"42","author":"Liu","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"R60-2-20210213","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbagen.2004.03.016","article-title":"O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress.","volume":"1673","author":"Zachara","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"R61-2-20210213","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00329.2005","article-title":"Hexosamines, insulin resistance, and the complications of diabetes: current status.","volume":"290","author":"Buse","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R62-2-20210213","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/jcb.20676","article-title":"O-GlcNAc cycling: how a single sugar post-translational modification is changing the way we think about signaling networks.","volume":"97","author":"Slawson","year":"2006","journal-title":"J Cell Biochem"},{"key":"R63-2-20210213","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/nature05815","article-title":"Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins.","volume":"446","author":"Hart","year":"2007","journal-title":"Nature"},{"key":"R64-2-20210213","doi-asserted-by":"crossref","first-page":"6104","DOI":"10.1038\/sj.onc.1203128","article-title":"Role of redox potential and reactive oxygen species in stress signaling.","volume":"18","author":"Adler","year":"1999","journal-title":"Oncogene"},{"key":"R65-2-20210213","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.pharmtox.45.120403.095902","article-title":"Glyceraldehyde-3-phosphate dehydrogenase, apoptosis, and neurodegenerative diseases.","volume":"45","author":"Chuang","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"R66-2-20210213","doi-asserted-by":"crossref","first-page":"4706","DOI":"10.1016\/S0021-9258(19)67706-9","article-title":"Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance.","volume":"266","author":"Marshall","year":"1991","journal-title":"J Biol Chem"},{"key":"R67-2-20210213","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1016\/S0021-9258(18)95943-0","article-title":"Studies on L-glutamine D-fructose 6-phosphate amidotransferase. I. Feedback inhibition by uridine diphosphate-N-acetylglucosamine.","volume":"242","author":"Kornfeld","year":"1967","journal-title":"J Biol Chem"},{"key":"R68-2-20210213","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0167-4838(02)00318-7","article-title":"Glucosamine-6-phosphate synthase-the multi-facets enzyme.","volume":"1597","author":"Milewski","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"R69-2-20210213","doi-asserted-by":"crossref","first-page":"9005","DOI":"10.1016\/S0021-9258(19)50380-5","article-title":"Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine:polypeptide beta-N-acetylglucosaminyltransferase.","volume":"267","author":"Haltiwanger","year":"1992","journal-title":"J Biol Chem"},{"key":"R70-2-20210213","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/S0021-9258(19)39838-2","article-title":"Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase.","volume":"265","author":"Haltiwanger","year":"1990","journal-title":"J Biol Chem"},{"key":"R71-2-20210213","doi-asserted-by":"crossref","first-page":"3308","DOI":"10.1016\/S0021-9258(17)43295-9","article-title":"Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc.","volume":"259","author":"Torres","year":"1984","journal-title":"J Biol Chem"},{"key":"R72-2-20210213","doi-asserted-by":"crossref","first-page":"8049","DOI":"10.1016\/S0021-9258(19)57510-X","article-title":"The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc.","volume":"261","author":"Holt","year":"1986","journal-title":"J Biol Chem"},{"key":"R73-2-20210213","doi-asserted-by":"crossref","first-page":"9316","DOI":"10.1074\/jbc.272.14.9316","article-title":"O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats.","volume":"272","author":"Lubas","year":"1997","journal-title":"J Biol Chem"},{"key":"R74-2-20210213","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1073\/pnas.100471497","article-title":"The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny.","volume":"97","author":"Shafi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R75-2-20210213","doi-asserted-by":"crossref","first-page":"32015","DOI":"10.1074\/jbc.274.45.32015","article-title":"Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats.","volume":"274","author":"Kreppel","year":"1999","journal-title":"J Biol Chem"},{"key":"R76-2-20210213","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1074\/jbc.M109656200","article-title":"Dynamic O-glycosylation of nuclear and cytosolic proteins: further characterization of the nucleocytoplasmic beta-N-acetylglucosaminidase, O-GlcNAcase.","volume":"277","author":"Wells","year":"2002","journal-title":"J Biol Chem"},{"key":"R77-2-20210213","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1074\/jbc.273.6.3611","article-title":"Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-d-glucopyranosylidene)amino-N-phenylcarbamate.","volume":"273","author":"Haltiwanger","year":"1998","journal-title":"J Biol Chem"},{"key":"R78-2-20210213","doi-asserted-by":"crossref","first-page":"11609","DOI":"10.1021\/bi000755i","article-title":"Alternative O-glycosylation\/O-phosphorylation of the murine estrogen receptor beta.","volume":"39","author":"Cheng","year":"2000","journal-title":"Biochemistry"},{"key":"R79-2-20210213","doi-asserted-by":"crossref","first-page":"10416","DOI":"10.1016\/S0021-9258(18)82216-5","article-title":"RNA polymerase II is a glycoprotein. Modification of the COOH-terminal domain by O-GlcNAc.","volume":"268","author":"Kelly","year":"1993","journal-title":"J Biol Chem"},{"key":"R80-2-20210213","doi-asserted-by":"crossref","first-page":"18961","DOI":"10.1074\/jbc.270.32.18961","article-title":"c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas.","volume":"270","author":"Chou","year":"1995","journal-title":"J Biol Chem"},{"key":"R81-2-20210213","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00125-003-1075-y","article-title":"P38 mitogen-activated protein kinase mediates hexosamine-induced TGF-beta1 mRNA expression in human mesangial cells.","volume":"46","author":"Burt","year":"2003","journal-title":"Diabetologia"},{"key":"R82-2-20210213","doi-asserted-by":"crossref","first-page":"F646","DOI":"10.1152\/ajprenal.2000.279.4.F646","article-title":"Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinases A and C.","volume":"279","author":"Singh","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"R83-2-20210213","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1042\/bj3240981","article-title":"Increased flux through the hexosamine biosynthesis pathway inhibits glucose transport acutely by activation of protein kinase C.","volume":"324","author":"Filippis","year":"1997","journal-title":"Biochem J"},{"key":"R84-2-20210213","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1126\/science.1075762","article-title":"The protein kinase complement of the human genome.","volume":"298","author":"Manning","year":"2002","journal-title":"Science"},{"key":"R85-2-20210213","doi-asserted-by":"crossref","first-page":"9838","DOI":"10.1074\/jbc.M010420200","article-title":"Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain.","volume":"276","author":"Gao","year":"2001","journal-title":"J Biol Chem"},{"key":"R86-2-20210213","doi-asserted-by":"crossref","first-page":"10695","DOI":"10.1073\/pnas.152346899","article-title":"Altered glycan-dependent signaling induces insulin resistance and hyperleptinemia.","volume":"99","author":"McClain","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R87-2-20210213","doi-asserted-by":"crossref","first-page":"53665","DOI":"10.1074\/jbc.M410406200","article-title":"Characterization of the histone acetyltransferase (HAT) domain of a bifunctional protein with activable O-GlcNAcase and HAT activities.","volume":"279","author":"Toleman","year":"2004","journal-title":"J Biol Chem"},{"key":"R88-2-20210213","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.2337\/diabetes.54.4.1214","article-title":": A single nucleotide polymorphism in MGEA5 encoding O-GlcNAc-selective N-acetyl-beta-d glucosaminidase is associated with type 2 diabetes in Mexican Americans.","volume":"54","author":"Lehman","year":"2005","journal-title":"Diabetes"},{"key":"R89-2-20210213","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1167\/iovs.03-0227","article-title":"Elevated expression of O-GlcNAc-modified proteins and O-GlcNAc transferase in corneas of diabetic Goto-Kakizaki rats.","volume":"44","author":"Akimoto","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R90-2-20210213","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s00795-004-0264-1","article-title":"O-GlcNAc modification of nucleocytoplasmic proteins and diabetes.","volume":"38","author":"Akimoto","year":"2005","journal-title":"Med Mol Morphol"},{"key":"R91-2-20210213","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/01.RES.0000165478.06813.58","article-title":"Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.","volume":"96","author":"Hu","year":"2005","journal-title":"Circ Res"},{"key":"R92-2-20210213","first-page":"921","article-title":"Regulation of specific DNA binding by p53: evidence for a role for O-glycosylation and charged residues at the carboxy-terminus.","volume":"12","author":"Shaw","year":"1996","journal-title":"Oncogene"},{"key":"R93-2-20210213","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1096\/fj.01-0094rev","article-title":"Glycan-dependent signaling: O-linked N-acetylglucosamine.","volume":"15","author":"Hanover","year":"2001","journal-title":"FASEB J"},{"key":"R94-2-20210213","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0006-291X(03)00175-X","article-title":"O-GlcNAc: a regulatory post-translational modification.","volume":"302","author":"Wells","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R95-2-20210213","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbrc.2004.08.023","article-title":"OGT functions as a catalytic chaperone under heat stress response: a unique defense role of OGT in hyperthermia.","volume":"322","author":"Sohn","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"R96-2-20210213","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1177\/039463200702000106","article-title":"Induction of macrophage glutamine: fructose-6-phosphate amidotransferase expression by hypoxia and by picolinic acid.","volume":"20","author":"Manzari","year":"2007","journal-title":"Int J Immunopathol Pharmacol"},{"key":"R97-2-20210213","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.yjmcc.2005.11.003","article-title":"Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia.","volume":"40","author":"Liu","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"R98-2-20210213","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.2337\/diabetes.53.12.3184","article-title":"Insulin stimulates and diabetes inhibits O-linked N-acetylglucosamine transferase and O-glycosylation of Sp1.","volume":"53","author":"Majumdar","year":"2004","journal-title":"Diabetes"},{"key":"R99-2-20210213","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1016\/j.febslet.2006.07.040","article-title":"O-linked N-acetylglucosamine suppresses thermal aggregation of Sp1.","volume":"580","author":"Lim","year":"2006","journal-title":"FEBS Lett"},{"key":"R100-2-20210213","doi-asserted-by":"crossref","first-page":"32099","DOI":"10.1074\/jbc.274.45.32099","article-title":"Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells.","volume":"274","author":"Dong","year":"1999","journal-title":"J Biol Chem"},{"key":"R101-2-20210213","doi-asserted-by":"crossref","first-page":"20165","DOI":"10.1074\/jbc.274.29.20165","article-title":"The inhibition of capacitative calcium entry due to ATP depletion but not due to glucosamine is reversed by staurosporine.","volume":"274","author":"Vemuri","year":"1999","journal-title":"J Biol Chem"},{"key":"R102-2-20210213","doi-asserted-by":"crossref","first-page":"14266","DOI":"10.1074\/jbc.M107167200","article-title":"Capacitative calcium entry contributes to nuclear factor of activated T-cells nuclear translocation and hypertrophy in cardiomyocytes.","volume":"277","author":"Hunton","year":"2002","journal-title":"J Biol Chem"},{"key":"R103-2-20210213","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.2337\/diabetes.51.12.3461","article-title":"Hyperglycemia inhibits capacitative calcium entry and hypertrophy in neonatal cardiomyocytes.","volume":"51","author":"Pang","year":"2002","journal-title":"Diabetes"},{"key":"R104-2-20210213","doi-asserted-by":"crossref","first-page":"C57","DOI":"10.1152\/ajpcell.00263.2005","article-title":"Glucosamine inhibits angiotensis II induced cytoplasmic Ca2+ elevation in neonatal cardiomyocytes via protein-associated O-GlcNAc.","volume":"290","author":"Nagy","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"R105-2-20210213","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.2337\/diabetes.53.4.1074","article-title":"The hexosamine pathway is responsible for the inhibition by diabetes of phenylephrine-induced inotropy.","volume":"53","author":"Pang","year":"2004","journal-title":"Diabetes"},{"key":"R106-2-20210213","doi-asserted-by":"crossref","first-page":"H1391","DOI":"10.1152\/ajpheart.00285.2007","article-title":"Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis.","volume":"293","author":"Liu","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R107-2-20210213","doi-asserted-by":"crossref","first-page":"C817","DOI":"10.1152\/ajpcell.00139.2004","article-title":"Calcium, ATP, and ROS: a mitochondrial love-hate triangle.","volume":"287","author":"Brookes","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"R108-2-20210213","doi-asserted-by":"crossref","first-page":"H1461","DOI":"10.1152\/ajpheart.00447.2001","article-title":"Preconditioning prevents alterations in cardiac SR gene expression due to ischemia-reperfusion.","volume":"282","author":"Temsah","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R109-2-20210213","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1152\/physrev.00013.2006","article-title":"Mitochondrial membrane permeabilization in cell death.","volume":"87","author":"Kroemer","year":"2007","journal-title":"Physiol Rev"},{"key":"R110-2-20210213","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1128\/MCB.17.5.2550","article-title":"Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility.","volume":"17","author":"Han","year":"1997","journal-title":"Mol Cell Biol"},{"key":"R111-2-20210213","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.bbrc.2003.11.074","article-title":"26S proteasome subunits are O-linked N-acetylglucosamine-modified in Drosophila melanogaster.","volume":"312","author":"Sumegi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R112-2-20210213","first-page":"3","article-title":"Emerging roles of proteasomes in ischemia-reperfusion injury of organs.","volume":"55","author":"Kukan","year":"2004","journal-title":"J Physiol Pharmacol"},{"key":"R113-2-20210213","doi-asserted-by":"crossref","first-page":"H919","DOI":"10.1152\/ajpheart.00851.2002","article-title":"J, Ardeshirpour F, McCain A, Bellinger DA, Merricks E, Adams J, Elliott PJ, Pien C, Fischer TH, Baldwin AS, Jr, et al.: Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.","volume":"284","year":"2003","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R114-2-20210213","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1089\/ars.2005.7.538","article-title":"Oxidized and ubiquitinated proteins may predict recovery of postischemic cardiac function: essential role of the proteasome.","volume":"7","author":"Powell","year":"2005","journal-title":"Antioxid Redox Signal"},{"key":"R115-2-20210213","doi-asserted-by":"crossref","first-page":"S170","DOI":"10.1111\/j.1753-4887.1998.tb01636.x","article-title":"Insulin resistance in burns and trauma.","volume":"56","author":"Carter","year":"1998","journal-title":"Nutr Rev"},{"key":"R116-2-20210213","doi-asserted-by":"crossref","first-page":"G107","DOI":"10.1152\/ajpgi.00217.2002","article-title":"Hemorrhage induces the rapid development of hepatic insulin resistance.","volume":"284","author":"Ma","year":"2003","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R117-2-20210213","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.CIR.0000155235.48601.2A","article-title":"Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study.","volume":"111","author":"Suleiman","year":"2005","journal-title":"Circulation"},{"key":"R118-2-20210213","doi-asserted-by":"crossref","first-page":"e436","DOI":"10.1161\/CIRCULATIONAHA.105.535732","article-title":"Implications and treatment of acute hyperglycemia in the setting of acute myocardial infarction.","volume":"115","author":"Zarich","year":"2007","journal-title":"Circulation"},{"key":"R119-2-20210213","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/eurheartj\/ehi884","article-title":": Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study.","volume":"27","author":"Goyal","year":"2006","journal-title":"Eur Heart J"},{"key":"R120-2-20210213","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/0002-9149(62)90035-8","article-title":"Effects of intravenous infusion of a potassium-insulin-glucose solution on the electrographic signs of myocardial infarction.","volume":"9","author":"Sodi-Pallares","year":"1962","journal-title":"Am J Cardiol"},{"key":"R121-2-20210213","first-page":"4","article-title":"Myocardial utilization of hypertonic glucose during hemorrhagic shock.","volume":"80","author":"Stremple","year":"1976","journal-title":"Surgery"},{"key":"R122-2-20210213","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00005373-198903000-00011","article-title":"A modified formula of GIK (glucose-insulin-potassium) therapy for treatment of extensive burn injury in dogs.","volume":"29","author":"Fang","year":"1989","journal-title":"J Trauma"},{"key":"R123-2-20210213","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.129.3.800","article-title":"Glucose-insulin and potassium infusions in septic shock.","volume":"129","author":"Hamdulay","year":"2006","journal-title":"Chest"},{"key":"R124-2-20210213","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/0003-4975(94)00917-V","article-title":"Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery.","volume":"59","author":"Svedjeholm","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"R125-2-20210213","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ejcts.2006.01.023","article-title":"Forty years of glucose-insulin-potassium (GIK) in cardiac surgery: a review of randomized, controlled trials.","volume":"29","author":"Schipke","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"R126-2-20210213","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1161\/01.CIR.96.4.1152","article-title":"Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials.","volume":"96","author":"Fath-Ordoubadi","year":"1997","journal-title":"Circulation"},{"key":"R127-2-20210213","first-page":"349","article-title":"Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.","volume":"2","year":"1988","journal-title":"Lancet"},{"key":"R128-2-20210213","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.285.13.1711","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial.","volume":"285","author":"Schwartz","year":"2001","journal-title":"JAMA"},{"key":"R129-2-20210213","first-page":"1115","article-title":"3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell'infarto Miocardico.","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"R130-2-20210213","doi-asserted-by":"crossref","first-page":"I239","DOI":"10.1161\/CIRCULATIONAHA.105.000760","article-title":": How does glucose insulin potassium improve hemodynamic performance? Evidence for altered expression of beta-adrenoreceptor and calcium handling genes.","volume":"114","author":"Ranasinghe","year":"2006","journal-title":"Circulation"},{"key":"R131-2-20210213","doi-asserted-by":"crossref","first-page":"I245","DOI":"10.1161\/CIRCULATIONAHA.105.000786","article-title":"Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.","volume":"114","author":"Ranasinghe","year":"2006","journal-title":"Circulation"},{"key":"R133-2-20210213","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/S0196-0644(97)70196-3","article-title":"2nd, Schroeder D, Williams C, Tomaszewski C, Raymond R: Insulin improves survival in a canine model of acute beta-blocker toxicity.","volume":"29","author":"Kerns","year":"1997","journal-title":"Ann Emerg Med"},{"key":"R134-2-20210213","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00139709-200423040-00002","article-title":"The role of insulin and glucose (hyperinsulinaemia\/euglycaemia) therapy in acute calcium channel antagonist and beta-blocker poisoning.","volume":"23","author":"Megarbane","year":"2004","journal-title":"Toxicol Rev"},{"key":"R135-2-20210213","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1345\/aph.1E436","article-title":"High-dose insulin therapy for calcium-channel blocker overdose.","volume":"39","author":"Shepherd","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R136-2-20210213","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1081\/CLT-100102437","article-title":"TH, Kerns WP, 2nd, Tomaszewski CA, Ford MD, Kline JA: Insulin-glucose as adjunctive therapy for severe calcium channel antagonist poisoning.","volume":"37","year":"1999","journal-title":"J Toxicol Clin Toxicol"},{"key":"R137-2-20210213","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/01.crd.0000175287.38905.14","article-title":"Glucose-insulin-potassium therapy in the era of coronary revascularization.","volume":"13","author":"Leos","year":"2005","journal-title":"Cardiol Rev"},{"key":"R138-2-20210213","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1006\/jmcc.1998.0647","article-title":"Effects of L-glutamine on post-ischaemic cardiac function: protection and rescue.","volume":"30","author":"Khogali","year":"1998","journal-title":"J Mol Cell Cardiol"},{"key":"R139-2-20210213","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0899-9007(01)00768-7","article-title":"Is glutamine beneficial in ischemic heart disease?","volume":"18","author":"Khogali","year":"2002","journal-title":"Nutrition"},{"key":"R140-2-20210213","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1097\/01.ccx.0000216582.87674.a4","article-title":"The glutamine story: where are we now?","volume":"12","author":"Wischmeyer","year":"2006","journal-title":"Curr Opin Crit Care"},{"key":"R141-2-20210213","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1177\/0115426503018005377","article-title":"Clinical applications of l-glutamine: past, present, and future.","volume":"18","author":"Wischmeyer","year":"2003","journal-title":"Nutr Clin Pract"},{"key":"R142-2-20210213","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/01.shk.0000196548.10634.02","article-title":"Oral glutamine enhances heat shock protein expression and improves survival following hyperthermia.","volume":"25","author":"Singleton","year":"2006","journal-title":"Shock"},{"key":"R143-2-20210213","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/01.shk.0000185795.96964.71","article-title":"Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis.","volume":"24","author":"Singleton","year":"2005","journal-title":"Shock"},{"key":"R144-2-20210213","doi-asserted-by":"crossref","first-page":"R1839","DOI":"10.1152\/ajpregu.00755.2006","article-title":"Glutamine's protection against sepsis and lung injury is dependent on heat shock protein 70 expression.","volume":"292","author":"Singleton","year":"2007","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R145-2-20210213","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s001250051599","article-title":"Presence of glutamine:fructose-6-phosphate amidotransferase for glucosamine-6-phosphate synthesis in endothelial cells: effects of hyperglycaemia and glutamine.","volume":"44","author":"Wu","year":"2001","journal-title":"Diabetologia"},{"key":"R146-2-20210213","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yjmcc.2006.09.015","article-title":"Glutamine-induced protection of isolated rat heart from ischemia\/reperfusion injury is mediated via the hexosamine biosynthesis pathway and increased protein O-GlcNAc levels.","volume":"42","author":"Liu","year":"2007","journal-title":"J Mol Cell Cardiol"},{"key":"R147-2-20210213","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/shk.0b013e3180487ebb","article-title":"Glucosamine administration improves survival rate after severe hemorrhagic shock combined with trauma in rats.","volume":"28","author":"Not","year":"2007","journal-title":"Shock"},{"key":"R148-2-20210213","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1136\/ard.2005.036368","article-title":"Low levels of human serum glucosamine after ingestion of glucosamine sulphate relative to capability for peripheral effectiveness.","volume":"65","author":"Biggee","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"R149-2-20210213","doi-asserted-by":"crossref","first-page":"39343","DOI":"10.1074\/jbc.M204924200","article-title":": Immunosuppressive effects of glucosamine.","volume":"277","author":"Ma","year":"2002","journal-title":"J Biol Chem"},{"key":"R150-2-20210213","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.4049\/jimmunol.166.8.5155","article-title":"N-Acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes.","volume":"166","author":"Shikhman","year":"2001","journal-title":"J Immunol"},{"key":"R151-2-20210213","doi-asserted-by":"crossref","first-page":"45759","DOI":"10.1074\/jbc.M407911200","article-title":"Neutrophils exhibit rapid agonist-induced increases in protein-associated O-GlcNAc.","volume":"279","author":"Kneass","year":"2004","journal-title":"J Biol Chem"},{"key":"R152-2-20210213","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diabetes.49.6.926","article-title":": Effects of glucosamine infusion on insulin secretion and insulin action in humans.","volume":"49","author":"Monauni","year":"2000","journal-title":"Diabetes"},{"key":"R153-2-20210213","first-page":"2099","article-title":"Short-term glucosamine infusion does not affect insulin sensitivity in humans.","volume":"86","author":"Pouwels","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R154-2-20210213","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1128\/MCB.24.4.1680-1690.2004","article-title":"Ogt-dependent X-chromosome-linked protein glycosylation is a requisite modification in somatic cell function and embryo viability.","volume":"24","author":"O'Donnell","year":"2004","journal-title":"Mol Cell Biol"}],"container-title":["Shock"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00024382-200804000-00002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:45:23Z","timestamp":1786038323000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00024382-200804000-00002"}},"subtitle":["THE FIRST LINE OF DEFENSE AGAINST STRESS, ISCHEMIA, AND TRAUMA"],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":153,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/shk.0b013e3181598bad","relation":{},"ISSN":["1073-2322"],"issn-type":[{"value":"1073-2322","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}